tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DWTX Stock Latest News

Dogwood Therapeutics Secures Licensing Deal with Serpin Pharma
Company AnnouncementsDogwood Therapeutics Secures Licensing Deal with Serpin Pharma
16h ago
8K
DWTX
Dogwood secures royalty free license to develop, commercialize SP16
PremiumThe Fly
Dogwood secures royalty free license to develop, commercialize SP16
17h ago
DWTX
Buy Rating for Dogwood Therapeutics: Promising Phase 2b Study Results and Strategic Financial Positioning
PremiumRatings
Buy Rating for Dogwood Therapeutics: Promising Phase 2b Study Results and Strategic Financial Positioning
1M ago
DWTX
Dogwood Therapeutics Reports Q2 2025 Financial Results
PremiumCompany Announcements
Dogwood Therapeutics Reports Q2 2025 Financial Results
2M ago
DWTX
Dogwood reports Q2 EPS ($1.99) vs ($1.15) last year
PremiumThe Fly
Dogwood reports Q2 EPS ($1.99) vs ($1.15) last year
2M ago
DWTX
Dogwood Therapeutics Approves CFO Salary Increase
PremiumCompany AnnouncementsDogwood Therapeutics Approves CFO Salary Increase
3M ago
8K
DWTX
Dogwood Therapeutics Approves Equity Plan Amendment
Premium
Company Announcements
Dogwood Therapeutics Approves Equity Plan Amendment
3M ago
8K
DWTX
Dogwood files $150M mixed securities shelf
Premium
The Fly
Dogwood files $150M mixed securities shelf
4M ago
DWTX
Promising Growth Potential for Dogwood Therapeutics with Halneuron’s Development and Strong Financial Position
PremiumRatings
Promising Growth Potential for Dogwood Therapeutics with Halneuron’s Development and Strong Financial Position
5M ago
DWTX
Buy Rating for Dogwood Therapeutics Driven by Promising Clinical Developments and Strong Financial Outlook
PremiumRatings
Buy Rating for Dogwood Therapeutics Driven by Promising Clinical Developments and Strong Financial Outlook
5M ago
DWTX
Dogwood Therapeutics Reports Progress in Pain Treatment Trials
PremiumCompany Announcements
Dogwood Therapeutics Reports Progress in Pain Treatment Trials
5M ago
DWTX
Dogwood reports Q1 EPS ($8.45) vs. ($1.68) last year
PremiumThe Fly
Dogwood reports Q1 EPS ($8.45) vs. ($1.68) last year
5M ago
DWTX
Dogwood sees cash runway through 1Q26
PremiumThe FlyDogwood sees cash runway through 1Q26
5M ago
DWTX
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
DYN
ANVS
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
APVO
DWTX
Dogwood upgraded to Buy from Neutral at H.C. Wainwright
PremiumThe Fly
Dogwood upgraded to Buy from Neutral at H.C. Wainwright
5M ago
DWTX
Dogwood receives Nasdaq confirmation of compliance
PremiumThe Fly
Dogwood receives Nasdaq confirmation of compliance
6M ago
DWTX
Dogwood management to meet with Maxim
PremiumThe Fly
Dogwood management to meet with Maxim
6M ago
DWTX
Dogwood regains Nasdaq compliance
PremiumThe Fly
Dogwood regains Nasdaq compliance
6M ago
DWTX
Dogwood Therapeutics Reports 2024 Financial Results and Strategic Progress
PremiumCompany AnnouncementsDogwood Therapeutics Reports 2024 Financial Results and Strategic Progress
6M ago
DWTX
Ten option delistings on March 24th
Premium
The Fly
Ten option delistings on March 24th
6M ago
GWH
ALGS
Dogwood doses first patient in Phase 2b trial of Halneuron
Premium
The Fly
Dogwood doses first patient in Phase 2b trial of Halneuron
7M ago
DWTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >